awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36299086-E535E992-F1D5-4FD3-95DF-498E945B3F89
Q36299086-E535E992-F1D5-4FD3-95DF-498E945B3F89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36299086-E535E992-F1D5-4FD3-95DF-498E945B3F89
Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial
P2860
Q36299086-E535E992-F1D5-4FD3-95DF-498E945B3F89
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36299086-E535E992-F1D5-4FD3-95DF-498E945B3F89
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2464361ad969a5f0a5eff61b645645d67c3d25f6
P2860
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial.